adenine has been researched along with 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, JA; Burrows, F; Chen, R; Chen, Y; Keating, MJ; Liu, C; Plunkett, W; Sivina, M; Thompson, PA; Tsai, J; Wierda, WG; Xiong, P | 1 |
1 other study(ies) available for adenine and 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
| Article | Year |
|---|---|
The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Apoptosis; Drug Synergism; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Receptors, Antigen, B-Cell; Signal Transduction; Tumor Cells, Cultured | 2021 |